Safety of CAR T-cell therapy in kidney transplant recipients-Reference-Cited by-同舟云学术

Safety of CAR T-cell therapy in kidney transplant recipients

Published:2021-05-06 Issue:18 Volume:137 Page:2558-2562
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Mamlouk Omar¹^ORCID,Nair Ranjit²,Iyer Swaminathan P.²,Edwards Angelina³,Neelapu Sattva S.²^ORCID,Steiner Raphael E.²^ORCID,Adkins Sherry A.²,Hawkins Misha²,Saini Neeraj⁴,Devashish Kartik²,Strati Paolo²,Mandayam Sreedhar¹^ORCID,Ahmed Sairah²^ORCID

Affiliation:

1. Section of Nephrology, Division of Internal Medicine and

2. Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX;

3. Division of Renal Disease and Hypertension, UTHealth McGovern Medical School, Houston, TX; and

4. Division of Cancer Medicine, Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/137/18/2558/1806488/bloodbld2020008759.pdf

Reference22 articles.

1. Post-transplantation lymphoproliferative disorders in adults;Dierickx;N Engl J Med,2018

2. Diffuse large B-cell lymphoma: R-CHOP failure—what to do?;Coiffier;Hematology Am Soc Hematol Educ Program,2016

3. Post-transplant lymphoproliferative disorders;Singavi;Cancer Treat Res,2015

4. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma;Neelapu;N Engl J Med,2017

5. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma;Schuster;N Engl J Med,2019

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers of outcome in patients undergoing CD19 CAR‐T therapy for large B cell lymphoma;HemaSphere;2024-08

2. Disrupting B and T-cell collaboration in autoimmune disease: T-cell engagers versus CAR T-cell therapy?;Clinical and Experimental Immunology;2024-04-20

3. Post-transplant lymphoproliferative disorders following kidney transplantation: A literature review with updates on risk factors, prognostic indices, screening strategies, treatment and analysis of donor type;Transplantation Reviews;2024-04

4. CAR T-Cell Therapy for Refractory Posttransplantation Lymphoproliferative Disorder in a Kidney Transplant Patient;Transplantation Direct;2024-02-26

5. Post-Transplant Lymphoproliferative Disorders;Seminars in Nephrology;2024-01